Your browser doesn't support javascript.
loading
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
De Stefano, Nicola; Tomic, Davorka; Radue, Ernst-Wilhelm; Sprenger, Till; Meier, Daniela Piani; Häring, Dieter; Sormani, Maria Pia.
Afiliação
  • De Stefano N; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. Electronic address: destefano@unisi.it.
  • Tomic D; Novartis Pharma AG, Basel, Switzerland.
  • Radue EW; Medical Image Analysis Center (MIAC), University Hospital, Basel, Switzerland.
  • Sprenger T; Department of Neurology, DKD Helios Klinik Wiesbaden, Germany.
  • Meier DP; Novartis Pharma AG, Basel, Switzerland.
  • Häring D; Novartis Pharma AG, Basel, Switzerland.
  • Sormani MP; University of Genoa, Genoa, Italy.
Mult Scler Relat Disord ; 7: 98-101, 2016 May.
Article em En | MEDLINE | ID: mdl-27237768

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Encéfalo / Esclerose Múltipla Recidivante-Remitente / Cloridrato de Fingolimode / Imunossupressores Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article